These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3076358)
1. [Management of anti-arrhythmia agents in patients with pacemakers]. Scanavacca M; Sosa EA; Martinelli Filho M Arq Bras Cardiol; 1988 Dec; 51(6):471-6. PubMed ID: 3076358 [No Abstract] [Full Text] [Related]
2. [Effect of anti-arrhythmia drugs on the heart conduction system]. Walczak F Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832 [No Abstract] [Full Text] [Related]
3. [Electrophysiological mechanisms of the anti-arrhythmia action of ethacizin]. Malakhov VI; Golitsyn SP; Sokolov SF; Smetnev AS Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):112-6. PubMed ID: 3541960 [No Abstract] [Full Text] [Related]
4. The influence of pacing rate and autonomic blockade on human primary and secondary atrial pacemakers. Ndrepepa G; Cina P; Gjini V; Kondili A; Balla I; Kastrati A Cardiologia; 1998 Mar; 43(3):287-93. PubMed ID: 9611857 [TBL] [Abstract][Full Text] [Related]
5. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect]. Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053 [TBL] [Abstract][Full Text] [Related]
6. [The effect of naloxone on rhythm disorders and on the conduction system of the heart]. Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581 [TBL] [Abstract][Full Text] [Related]
7. [Cellular mechanisms of cardiac arrhythmias. II. Conduction disorders]. Beresewicz A Kardiol Pol; 1986; 29(1):60-74. PubMed ID: 3523001 [No Abstract] [Full Text] [Related]
8. The pharmacology of cardio-active agents. Hayes AH Cardiovasc Clin; 1972; 4(3):103-18. PubMed ID: 4130206 [No Abstract] [Full Text] [Related]
13. [Physiopathological and clinical significance of the recovery time of the sinus node]. Polimeni RM; Abate G; Zagà F; Procopio P; Guelfi G Boll Soc Ital Cardiol; 1976; 21(4):707-13. PubMed ID: 1031036 [No Abstract] [Full Text] [Related]
14. [The effect of a new anti-arrhythmia agent, a diethylamine analog of ethmozine, on the electrophysiological indices of the sinoatrial node in patients with its normal function and dysfunction]. Rozenshtraukh LV; Shugushev KhKh; Smetnev AS Ter Arkh; 1983; 55(5):84-8. PubMed ID: 6351326 [No Abstract] [Full Text] [Related]
15. [Perspectives in anti-arrhythmia pharmacological therapy]. Furlanello F; Vergara G; Inama G; Dal Forno P; Bettini R; Disertori M Cardiologia; 1984; 29(1-2):73-84. PubMed ID: 6442869 [No Abstract] [Full Text] [Related]
16. The management of arrhythmias. Med Times; 1980 Jan; 108(1):29-100. PubMed ID: 7374395 [No Abstract] [Full Text] [Related]
17. Transesophageal electrocardiography and cardiac pacing: state of the art. Benson DW Circulation; 1987 Apr; 75(4 Pt 2):III86-92. PubMed ID: 3829365 [No Abstract] [Full Text] [Related]
18. How do atrial pacing algorithms prevent atrial arrhythmias? Mitchell AR; Sulke N Europace; 2004 Jul; 6(4):351-62. PubMed ID: 15172660 [TBL] [Abstract][Full Text] [Related]
19. Managing cardiac arrhythmias. Part I. General principles of investigation and management. Kamath S; Lip GY Practitioner; 2000 Jun; 244(1611):559, 560, 563-5. PubMed ID: 10962848 [No Abstract] [Full Text] [Related]
20. Incidence and management of dysrhythmias after Fontan procedure. Porter CJ; Garson A Herz; 1993 Oct; 18(5):318-27. PubMed ID: 8258437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]